Analyst consensus rating
Estrella Immunopharma Analyst Rating: none
Direct answer
Estrella Immunopharma's consensus rating is none.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $12.00.
Forecast evidence checked November 13, 2026.
Get free Estrella Immunopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.52
- Average price target
- $12.00
- High price target
- $12.00
- Low price target
- $12.00
- Low target gap
- +2,212.6%
- Target upside
- +2,212.6%
- High target gap
- +2,212.6%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- November 13, 2026
- Valid through
- November 20, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Estrella Immunopharma?
Estrella Immunopharma has a verified none consensus. The same dataset has an average price target of $12.00.
How far are Estrella Immunopharma's low and high targets from the recorded price?
The low target implies +2,212.6%, while the high target implies +2,212.6%.
How many analysts are included in Estrella Immunopharma's consensus?
The verified consensus includes 1 analysts.
How is Estrella Immunopharma's target upside or downside calculated?
The average target of $12.00 is divided by the recorded price of $0.52, then one is subtracted to produce +2,212.6%. This does not guarantee a future return.
When was Estrella Immunopharma's analyst forecast verified?
The data was verified on 2026-11-13. The dataset is valid through 2026-11-20.